Charles Schwab Investment Management Inc Eyenovia, Inc. Transaction History

Charles Schwab Investment Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$0.52 - $1.06 $33,058 - $67,388	-63,574 Reduced 83.72%	12,362 $7,000
Q2 2023 Aug 09, 2023	BUY	$2.21 - $5.75 $140,498 - $365,550	63,574 Added 514.27%	75,936 $179,000
Q1 2023 May 11, 2023	SELL	$1.72 - $3.53 $20,984 - $43,066	-12,200 Reduced 49.67%	12,362 $43,000
Q3 2022 Nov 14, 2022	BUY	$1.55 - $2.48 $38,071 - $60,913	24,562 New	24,562 $49,000

13.4M

13.1K

21.3K

Ticker EYEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,212,900
Market Cap $3.42M
Description
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the develop...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.